Synapse - Works

Results (2639)

A phase I study of IMGN529, an antibody-drug conjugate (ADC) targeting CD37, in adult patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Stathis, A.; Freedman, A. S.; Flinn, I. W.; Maddocks, K. J.; Weitman, S.; Berdeja, J. G.; Mejia, A. V.; Zucca, E.; Green, R.; Romanelli, A.; more...
Blood (2014)

Fulltext@MSK | Save

A systemic xenograft model of Waldenstrom's macroglobulinemia demonstrates the potent anti-tumor effect of second generation CD19 directed chimeric antigen receptor modified T cells in this disease

Meeting Abstract

Smith, E. L.; Palomba, M. L.; Park, J. H.; Brentjens, R. J.
Blood (2014)

Fulltext@MSK | Save

Subsequent hematopoietic stem cell transplantation in belinostat-treated patients with relapsed/refractory peripheral T-cell lymphoma (R/R PTCL)

Meeting Abstract

Shustov, A. R.; Al-Ali, H. K.; Wulf, G.; Hsu, P.; Choi, M. R.; Allen, L. F.; Visser, O. J.; Zachee, P.; Horwitz, S. M.
Blood (2014)

Fulltext@MSK | Save

Targeted therapy of B cell lymphoma with a direct inhibitor of the NF-kappa B subunit c-Rel

Meeting Abstract

Shono, Y.; Tuckett, A. Z.; Liou, H. C.; Ouk, S.; Doubrovina, E.; Doubrovin, M.; Derenzini, E.; Scallion, M. I.; Tsai, J. J.; Smith, O. M.; more...
Blood (2014)

Fulltext@MSK | Save

AG-221, a small molecule mutant IDH2 inhibitor, remodels the epigenetic state of IDH2-mutant cells and induces alterations in self-renewal/differentiation in IDH2-mutant AML model in vivo

Meeting Abstract

Shih, A. H.; Shank, K. R.; Meydan, C.; Intlekofer, A. M.; Ward, P.; Thompson, C. B.; Melnick, A. M.; Travins, J.; Straley, K.; Gliser, C.; more...
Blood (2014)

Fulltext@MSK | Save

Second interim analysis of a phase 3 study of idelalisib (ZYDELIG®) plus rituximab (R) for relapsed chronic lymphocytic leukemia (CLL): Efficacy analysis in patient subpopulations with del(17p) and other adverse prognostic factors

Meeting Abstract

Sharman, J. P.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
Blood (2014)

Fulltext@MSK | Save

A Cutaneous Lymphoma International Consortium 'CLIC' study of prognostic parameters in advanced stages of mycosis fungoides and Sezary syndrome: Progress towards establishing a prognostic index to augment clinical staging

Meeting Abstract

Scarisbrick, J. J.; Quaglino, P.; Vermeer, M.; Whittaker, S.; Wood, G. S.; Duvic, M.; Prince, M.; Horwitz, S. M.; Hoppe, R. T.; Porcu, P.; more...
Blood (2014)

Fulltext@MSK | Save

Safe and effective treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) and low baseline platelet counts with belinostat

Meeting Abstract

Savage, K. J.; Horwitz, S. M.; Zinzani, P. L.; Van Hoof, A.; Assouline, S. E.; Bhat, G.; Choi, M. R.; Allen, L. F.; Ben-Yehuda, D.; Jurczak, W.; more...
Blood (2014)

Fulltext@MSK | Save

Interim safety analysis: A phase I trial of high dose therapy and autologous stem cell transplantation followed by infusion of chimeric antigen receptor modified T-cells (19-28z CAR-T) directed against CD19+B-cells for relapsed and refractory aggressive B cell non-Hodgkin lymphoma (B-NHL)

Meeting Abstract

Sauter, C. S.; Riviere, I.; Bernal, Y. J.; Wang, X. Y.; Purdon, T. J.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
Blood (2014)

Fulltext@MSK | Save

AMC075: The combination of vorinostat with chemotherapy and rituximab is tolerable and feasible in HIV-related B-cell non-Hodgkin's lymphoma with high-risk features

Meeting Abstract

Ramos, J. C.; Sparano, J.; Moore, P.; Lee, J. Y.; Rudek, M. A.; Ambinder, R. F.; Cesarman, E.; Noy, A.; Mitsuyasu, R. T.
Blood (2014)

Fulltext@MSK | Save